These findings align well with human studies, particularly in patients with heart failure with reduced ejection fraction (HFrEF), where elevated plasma renalase levels are consistently reported and correlate with markers of adverse cardiac remodelling, reduced systolic function (LVEF), and ischaemia. Here, RNLS is linked to heart failure.